An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Andrei Thomas‐Tikhonenko|Cancer Research|2024Cited by 10
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic LeukemiaManuel Torres-Diz, Andrei Thomas‐Tikhonenko|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0